|
ZNF605 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.90909526970518E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.23459958607009E-10 |
| Normal-vs-Stage2 |
1.413960E-02 |
| Normal-vs-Stage3 |
2.371800E-02 |
| Normal-vs-Stage4 |
6.975700E-02 |
| Stage1-vs-Stage2 |
8.188800E-01 |
| Stage1-vs-Stage3 |
2.164600E-01 |
| Stage1-vs-Stage4 |
7.743400E-01 |
| Stage2-vs-Stage3 |
5.481000E-01 |
| Stage2-vs-Stage4 |
9.371000E-01 |
| Stage3-vs-Stage4 |
6.782400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.53939971880845E-10 |
| Normal-vs-AfricanAmerican |
3.99369999959376E-07 |
| Normal-vs-Asian |
9.759800E-01 |
| Caucasian-vs-AfricanAmerican |
5.252000E-01 |
| Caucasian-vs-Asian |
6.523800E-02 |
| AfricanAmerican-vs-Asian |
6.442400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.71830377388483E-11 |
| Normal-vs-Female |
9.95729999564432E-08 |
| Male-vs-Female |
7.270200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.74810000000059E-05 |
| Normal-vs-Extreme_Weight |
1.59292999999394E-05 |
| Normal-vs-Obese |
1.8956000003012E-07 |
| Normal-vs-Extreme_Obese |
6.281800E-03 |
| Normal_Weight-vs-Extreme_Weight |
6.915200E-01 |
| Normal_Weight-vs-Obese |
3.526800E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.709800E-01 |
| Extreme_Weight-vs-Obese |
1.393550E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.777200E-01 |
| Obese-vs-Extreme_Obese |
8.007800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.923400E-03 |
| Normal-vs-Age(41-60Yrs) |
3.31046301482729E-12 |
| Normal-vs-Age(61-80Yrs) |
9.39469999572395E-08 |
| Normal-vs-Age(81-100Yrs) |
3.292800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.043200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.440000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.950500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.099700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.709700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.976590E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.63180580159406E-12 |
| Normal-VS-Type2 PRCC |
6.882100E-02 |
| Normal-VS-KIRP CIMP |
3.439800E-01 |
| Normal-VS-Unclassified PRCC |
4.3906000000038E-05 |
| Type1 PRCC-VS-Type2 PRCC |
1.48290268953133E-11 |
| Type1 PRCC-VS-KIRP CIMP |
2.862000E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
9.285200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.566000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.758500E-04 |
| KIRP CIMP-VS-Unclassified PRCC |
1.072960E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.639670E-03 |
| Normal-vs-N1 |
1.063700E-02 |
| Normal-vs-N2 |
1.345950E-01 |
| N0-vs-N1 |
7.928000E-01 |
| N0-vs-N2 |
7.880600E-01 |
| N1-vs-N2 |
7.001400E-01 |
|
|
